MedTrace Logo

The Role of Sleep Disordered Breathing in Heart Failure Admissions

NCT02505867 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-06-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of in-hospital diagnosis and treatment of sleep disordered breathing (SDB) on post-discharge mortality and readmissions in- hospitalized patients with acute heart failure syndrome and reduced ejection fraction (HFrEF).

Conditions

Interventions

DEVICE

Adaptive Servo Ventilation

Participants are provided with an Adaptive Servo Ventilation (ASV) device for targeted treatment of SDB during inpatient hospitalization or shortly after discharge.

Sponsors & Collaborators

  • Philips Respironics

    collaborator INDUSTRY

  • Rami Khayat

    lead OTHER

Principal Investigators

  • Rami Khayat, MD · Ohio State University

  • William Abraham, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-12-01
Completion
2016-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02505867 on ClinicalTrials.gov